Introduction
Innate immunity is the crucial first line of defence against microbial challenge. The genes involved in innate immunity encode microbefighting peptides and cytokines, which can kill pathogens and induce inflammation. When unchecked these inflammatory mediators can cause septic shock and promote autoimmune diseases, such as multiple sclerosis, type 1 diabetes mellitus and rheumatoid arthritis (Grateau, 2006) . Anti-microbial peptides (AMPs) are activated by the two major innate immunity pathways, the Toll-interleukin-1 (IL-1) pathway and the immune-deficiency (IMD)-tumour necrosis factor a (TNFa/Eiger)pathway, which are highly conserved in evolution, from insects to humans (Lemaitre and Hoffmann, 2007; Leulier and Lemaitre, 2008) . This species conservation makes Drosophila a valuable model to study the molecular events that regulate the innate immune response.
The generation of an innate immune response in Drosophila is mediated by the fat body (the humoural response tissue, analogous to the vertebrate liver), blood cells called haemocytes (the cellular response) and other tissues, such as the gut and trachea, which form a barrier between the environment and the living organism Hultmark and Borge-Renberg, 2007; Lemaitre and Hoffmann, 2007) . If this barrier is breached bacterial pathogens can enter the haemolymph, where they are recognised by specific secreted or membrane bound peptidoglycan-recognition protein receptors (PGRPs) and Gram-negative-binding proteins (GNBPs), which act to trigger either the Toll or immune deficiency (IMD) signalling cascades in immune response tissues. Microbial challenge activates the host fat body cells to secrete various antimicrobial peptides (AMPs), including Diptericin (Dpt) and Drosomycin (Drs) (Imler and Bulet, 2005) . The secretion of these anti-microbial peptides is an essential step in the immune response.
Endocytosis and exocytosis are directly involved in the immune response in eukaryotes (Robatzek, 2007; Stow et al., 2006) . For example, endosomal compartments contain internalised Toll and Toll-like receptors, which activate the downstream signalling cascades (Husebye et al., 2006) . A final step in the immune response involves the exocytosis of immune response mediators, such as AMPs (Batoni et al., 2006; Maisetta et al., 2008; Urbe et al., 1993) . Although some of the molecular events in anterograde protein trafficking from the Golgi to the plasma membrane have been described, the molecular machinery involved in regulating the final stages of vesicular exocytosis are yet to be fully elucidated. The small GTPases Rab4 and Rab11, which function in recycling endosomes, have been implicated in the anterograde traffic of soluble cargo. Rab11 is essential for vesicle targeting to the plasma membrane (Menager et al., 2007; Sonnichsen et al., 2000; Ullrich et al., 1996; Ward et al., 2005; Zerial and McBride, 2001) . At the plasma membrane, these Rab11-positive vesicles are recognised by SNARE [soluble-N-ethylmaleimide-sensitive factor accessoryprotein (SNAP) receptor] and Syntaxin proteins, which are involved in the final stages of exocytosis and secretion . Some immune-deficiency disorders are known to be caused by the loss of function of proteins involved in the vesicular machinery. Mutations in endosomal proteins are associated with immune diseases, such as Griscelli and Hermansky-Pudlak syndromes (Ménasché et al., 2000; Stow et al., 2006) . In mammals, SNAREs are crucial for vesicle degranulation and the subsequent release of inflammatory mediators or cytokines, from the secretory granules in mast cells, eosinophils, neutrophils and platelets (Kay et al., 2006; Logan et al., 2006; Manderson et al., 2007; Stow et al., 2006) . Patients with mutations in the SNARE protein Sec1/Vps33B exhibit bleeding problems associated with defects in megakaryocyte and platelet alpha-granule release (Lo et al., 2005) . New elements of the vesicular secretion machinery are being realised on the basis of immune-deficiency disorders.
There have been several reports implicating 14-3-3 proteins in traffic to the plasma membrane (Shikano et al., 2005; Tzivion and Avruch, 2002; Tzivion et al., 2001) . The 14-3-3 family of phosphorylated-serine-binding proteins is highly conserved from yeast to man, and in mammals comprises seven isoforms (, , , , ,  and ) (Tzivion and Avruch, 2002; Yang et al., 2006 ). 14-3-3 proteins are dimeric with homodimers and heterodimers formed between most isoforms (Messaritou et al., 2010) . The 14-3-3 dimer structure comprises nine a-helixes arranged to form an internal pocket that provides a surface for interaction with a large number of phosphorylated-serine target proteins, some of which have been identified by proteomic analysis (Darling et al., 2005; Mackintosh, 2004; Pozuelo Rubio et al., 2004; Yang et al., 2006) . Understanding the biological role of 14-3-3 proteins in vivo is extremely difficult given their functional redundancy in mammals. Drosophila, however, has only two 14-3-3 homologues, 14-3-3 and 14-3-3, which have 82% and 88% sequence identity to the respective mammalian orthologues and also exhibit functional conservation (Benton et al., 2002; Broadie et al., 1997; Li et al., 1997; Skoulakis and Davis, 1998; Su et al., 2001) . Therefore, Drosophila represents a unique and tractable model in which to determine the in vivo function of 14-3-3 proteins. We have taken advantage of a Drosophila model, to show that 14-3-3 plays an important role in innate immunity.
Results

Loss of 14-3-3 results in Drosophila susceptibility to acute bacterial infection
Both Drosophila 14-3-3 and 14-3-3 are broadly expressed throughout development and their transcripts and proteins can be detected in most, if not all, embryonic and larval tissues (Fig. 1A) . As previously described, the loss of 14-3-3 (Fig. 1B , lane 2) resulted in embryonic lethality even in the presence of functional 14-3-3 (Acevedo et al., 2007) . By contrast, neither 14-3-3 j2B10 homozygotes (protein null allele; Fig. 1B , lane 3) nor 14-3-3 j2B10/E183K transheterozygotes [protein null allele and antimorphic allele carrying the E183K point mutation (Benton et al., 2002); Fig. 1B, lane 4] showed impaired viability for the third-instar larvae when compared with wild-type larvae [ Fig. 1C,D ; see no bacterial treatment (-)]. Given that viability of 14-3-3 mutants was normal under steady-state conditions and that 14-3-3 was detected in all immune response third-instar larval tissues (i.e. fat body, gut and haemocytes, Fig.  1A ), we hypothesised that 14-3-3 was essential for the immune response under conditions of challenge. To address this question we infected either wild-type or 14-3-3 mutant Drosophila, through the natural oral route. Early third-instar larvae were incubated at 29°C with a suspension of either Gram-negative Escherichia coli (E. coli) (for 11 hours, Fig. 1C ) or Gram-positive Micrococcus luteus (M. luteus) bacteria (for 7 hours, Fig. 1D ). The surviving larvae and pupae were scored at 6-hour intervals. Whereas the survival of wild- Immune-response tissues differentiate normally in 14-3-3 mutant larvae
To exclude the possibility of abnormal fat body and haemocyte development in 14-3-3 mutants, we performed morphological analysis on these tissues. There were no obvious defects in the size, overall tissue morphology or apoptosis of the fat body or Fig. S1A-F) . In addition, similar amounts of Dronc caspase (Dorstyn and Kumar, 2008) cleavage products were detected on western blots from both mutant and wild-type fat body tissue lysates, indicating similar levels of apoptosis (supplementary material Fig. S1G ). One of the characteristics of a fully differentiated fat body is the accumulation of lipids as lipid droplets (Beller et al., 2006) . There was no apparent change in content and distribution of neutral lipids or cholesterol observed in 14-3-3 mutant flies (detected by Nile Red or Fillipin staining, respectively; supplementary material Fig 
Defective secretion of Drs from immune-response cells in 14-3-3 mutants
The susceptibility of 14-3-3 mutant larvae to oral infection suggested a specific defect in immune function. To study the underlying molecular cause, we tested whether transcriptional activation of AMPs occurred in the fat bodies of 14-3-3 mutant third-instar larvae. We assessed the amount of Drs and Dpt transcripts as a measure of activating the Toll (sensing Grampositive bacteria) and IMD (sensing Gram-negative bacteria) signalling pathways. This was assessed by qRT-PCR, in wild-type and mutant fat body tissues, either with or without oral bacterial challenge (Gram-positive M. luteus or Gram-negative E. coli, 4 hours at 25°C). No differences were observed in the basal levels of the AMP transcriptional activation between wild-type and 14-3-3 mutant samples (supplementary material Fig. S2 ). Under the mild oral immune challenge conditions, both wild-type and 14-3-3 mutant fat body cells exhibited a similar trend of transcriptional upregulation for both Drs and Dpt when compared with the fat body cells from non-challenged larvae (supplementary material Fig. S2 ). These results indicate that the lack of 14-3-3 protein does not impair the transcriptional activation of Toll and IMD pathways.
To demonstrate that AMP transcripts were translated in 14-3-3 mutants, we employed a previously characterised Drs-GFP transgene, the expression of which is controlled by the endogenous Drs promoter and is therefore responsive to the activation of the Toll pathway (Ferrandon et al., 1998) . This Drs-GFP fusion protein retains the native secretion signal peptide sequence and has been shown to be secreted into the haemolymph (Ferrandon et al., 1998) . The detection of Drs-GFP signal in fat body and haemocytes cells from 14-3-3 mutant larvae, following oral bacterial stimulation with M. luteus, indicated no defect in the translation of this secretory AMP ( Fig To investigate whether Drs-GFP was secreted into the haemolymph we quantified the intensity of GFP signal in haemolymph samples from the wild-type and 14-3-3 mutants (Fig. 3C,D) . This analysis showed a 34.5% reduction in the intensity of Drs-GFP haemolymph signal in 14-3-3 mutants when compared with that in wild-type, indicating reduced Drs-GFP secretion in the mutants. This reduced secretion coincided with abnormal accumulation of Drs-GFP-positive vesicles near the plasma membrane of 14-3-3 mutant cells, when compared with that in wild-type controls ( Fig. 2A,B ; Fig. 3A ,B; Fig. 4B ,C). This suggests that there is a potential problem in the AMP delivery process, possibly either at the recycling endosome or at the plasma membrane. 2167 14-3-3 is a regulator of innate immunity 
Recycling endosomes and Drs delivery
We investigated the intracellular trafficking of Drs and its relationship to Rab11-and Rab4-positive recycling endosomes, which are involved in cargo delivery to the plasma membrane (Clarke et al., 2006; Sato et al., 2008; Satoh et al., 2005; Ward et al., 2005) . In wild-type cells, Drs-GFP was included into Rab4-mRFP-positive (Fig. 4A ) and Rab11-positive vesicles (Fig. 4B) . The RNA interference (RNAi)-mediated silencing of Rab4 resulted in the accumulation of Drs-GFP, mainly within the perinuclear region of fat body cells (compare Fig. 2C with 2A) , and correlated with a 53% reduction in the intensity of Drs-GFP signal in the haemolymph, indicating reduced secretion (Fig. 3C,D) . The RNAi silencing of Rab11 also led to the perinuclear accumulation of Drs-GFP in most fat body cells (Fig. 2D ), but this did affect Drs-GFP expression, as well as morphology and possibly integrity in some cells. On the basis of this irregular Drs-GFP expression in fat body cells, the Rab11
RNAi haemolymph sample was omitted from the analysis. These results suggest a role for Rab4 and Rab11 in the anterograde traffic of Drs-GFP from the perinuclear region towards the plasma membrane. There did not appear to be any disruption to recycling endosome compartments in 14-3-3 mutants because in both wild-type and 14-3-3 mutants there was a similar distribution and number of the Rab11-GFP and Rab4-mRFP double-positive vesicles (Fig. 4D,E) .
Drs and small Rab11-positive vesicles are concentrated near the plasma membrane in cells from 14-3-3 mutants Having shown the abnormal distribution and secretion of Drs in 14-3-3 mutants ( Fig. 2A,B; Fig. 3A,B) , we investigated further the Rab11-positive vesicles that are involved in vesicle targeting to the plasma membrane. In the wild-type and 14-3-3 mutant fat body cells, Drs-GFP was found inside small Rab11-positive vesicles that were located near the plasma membrane (detected by an anti-Rab11 antibody; Fig. 4B ,C). There was, however, an accumulation of small Rab11-positive vesicles at the plasma membrane of 14-3-3 mutant fat body cells, but not in the wildtype fat body, as established by anti-Rab11 antibody staining (Fig.  5A ,C) and Rab11-GFP fusion protein expression (using the fatbody-and haemocyte-specific driver CG-GAL4; Fig. 5B,D) . Ultrastructural analysis by electron microscopy demonstrated some vesicles near the plasma membrane of wild-type fat body cells, but there were more vesicles in 14-3-3 mutant cells (supplementary material Fig. S3 ). Quantitative analysis showed a significant increase (P<0.05) in the number of Rab11-positive vesicles in 14-3-3 mutants when compared with that in wild-type controls (Fig.  5E) .
To confirm the specificity of the Rab11-vesicular phenotype with the loss of 14-3-3 protein, a copy of wild-type 14-3-3 cDNA was introduced into the 14-3-3 mutant background, using the fat-body-and haemocyte-restricted expression of CG-GAL4>UAS-14-3-3 transgenes ('rescue assay'). The number of Rab11-GFP-positive vesicles in the rescue assay did not differ significantly from that in the wild type (Fig. 5E, ). In addition, the fat-body-restricted RNAi silencing of 14-3-3 by expression of CG- RNAi transgenes produced a phenotype similar to that of 14-3-3 mutants (Fig. 5E) . Together, this indicates that the phenotype is caused by the loss of 14-3-3 in haemocytes and fat body tissues. The role of the 14-3-3 homologue was also investigated in wild-type and 14-3-3 mutant backgrounds using CG-GAL4>UAS-14-3-3 RNAi transgenic expression. The RNAi silencing of 14-3-3 also increased the number of Rab11-GFP-positive vesicles located at the plasma membrane when compared with that in wild-type controls (Fig.  5E , ). However, the number of plasma membrane associated vesicles was significantly higher in 14-3-3 mutants when compared with that upon 14-3-3 RNAi silencing (Fig. 5E) . Moreover, introduction of the 14-3-3
RNAi transgene into the 14-3-3 mutants did not significantly increase the number of membranelocalised Rab11-GFP vesicles when compared with that in the 14-3-3 mutant alone (Fig. 5E, UAS ). There was a similar number of vesicles accumulating at the plasma membrane in 14-3-3
RNAi cells when compared with that in the 'rescued' 14-3-3 mutants. These results suggest that there is a substantial role for Drosophila 14-3-3 in the control of Rab11-positive vesicles in the fat body and a lesser functional role for 14-3-3.
2168 Journal of Cell Science 123 (13) Next, we examined the distribution of 14-3-3 in relation to the Rab11-positive vesicles. In wild-type Drosophila, 14-3-3 was observed as punctuate staining in close proximity to Rab11-GFPpositive vesicles (Fig. 6A,B) . In addition, 14-3-3 occasionally colocalised with the vesicular Syntaxin proteins, especially near the plasma membrane (Fig. 6C) . The phenotype of RNAi silencing of Drosophila Syntaxin 1a (Syx1a) closely mimicked the phenotype seen for the 14-3-3 mutants, namely the accumulation of Drs-GFP, Rab11-positive vesicles near the plasma membrane and a 63% reduction in the Drs-GFP signal in the haemolymph ( Fig. 2E ; Fig. 3D; Fig. 5E ). Given the function of Syx1a as a component of the exocytic machinery (Gladycheva et al., 2007; Murray et al., 2005; Pagan et al., 2003) , the similarity between the 14-3-3 and the Syx1a
RNAi phenotypes suggests that 14-3-3 has a role in regulating exocytosis.
Discussion
Members of the evolutionary conserved 14-3-3 family of proteins have previously been implicated in the regulation of various signalling pathways for cell survival, proliferation and development (Acevedo et al., 2007; Benton et al., 2002; Broadie et al., 1997; Chen et al., 2003; Darling et al., 2005; Grammenoudi et al., 2008; Guthridge et al., 2004; Guthridge et al., 2006; Karam et al., 2010; Li et al., 1997; Skoulakis and Davis, 1996; Skoulakis and Davis, 1998; Su et al., 2001; Thomas et al., 2005) . However, the specific action of these proteins has been difficult to define, mainly because of the functional redundancy between 14-3-3 homologues in vertebrates. In Drosophila there are only two homologues, 14-3-3 and 14-3-3, and therefore Drosophila represent an appealing in vivo system in which to study the role of distinct 14-3-3 isoforms. Despite 14-3-3 and 14-3-3 having a high degree of sequence identity (62%) (Skoulakis and Davis, 1998) , functional differences have begun to emerge. Thus, whereas 14-3-3 protein-null mutants are embryonic lethal, suggesting a crucial role in embryonic development, 14-3-3 mutants survive to adulthood and exhibit no obvious morphological or functional defects, except for sterility (Acevedo et al., 2007; Benton et al., 2002; Messaritou et al., 2010) . These results raised the possibility that 14-3-3 was required for some tissue-specific functions. 2169 14-3-3 is a regulator of innate immunity Here, we have shown that 14-3-3 mutant larvae had significantly reduced survival rates when orally infected with bacteria, indicating an important role for 14-3-3 in innate immunity. Developmental, differentiation and metabolic defects were excluded as the cause of the observed phenotype in Drosophila 14-3-3 mutants by demonstrating similar survival rates for the respective developmental stages in wild-type Drosophila. Thus, there was no obvious change in the level of apoptosis in these tissues, with equivalent Dronc caspase cleavage in 14-3-3 mutant and wildtype Drosophila. Even under conditions of immune challenge there were no identifiable defects in the morphology or maturity of immune response tissues, including the haemocytes and fat body.
Studies over the past decade have provided some understanding as to how the two evolutionary conserved pathways of Toll/IL-1 receptor and IMD-TNFa/Eiger (Govind and Nehm, 2004) control innate immunity, in response to a specific microbial challenge. For example, immune challenge leads to a rapid and prolific transcriptional activation of AMPs (Imler and Bulet, 2005) . In immune-challenged 14-3-3 mutants, the key genes of the Toll and IMD immune response pathways were activated, resulting in Drs and Dpt AMP expression. There was therefore a normal transcriptional initiation of the immune response in Drosophila 14-3-3 mutants. In the absence of any immune challenge, AMPs might still have been activated in a transcriptional factor FOXO/Forkhead-dependent-manner (Becker et al., 2010) , because 14-3-3 proteins are known to bind phosphorylated FOXO, which can prevent nuclear translocation and transcriptional activation of FOXO target genes (van der Heide et al., 2004) . However, our analysis of 14-3-3 mutants in the absence of microbial challenge showed no abnormal AMP activation, suggesting that 14-3-3 did not have a role in AMP transcriptional regulation.
In Drosophila, AMPs function as immune mediators, and the regulation of their secretion is a crucial step in organism selfdefence (Imler and Bulet, 2005) . Here, 14-3-3 mutants demonstrated impaired secretion of the antimicrobial peptide Drs, into the haemolymph and concomitant accumulation of Drs-positive 2170 Journal of Cell Science 123 (13) ) of Rab11-positive vesicles scored in two squares (19.6mm ϫ19.6mm, shown in yellow in A and B) per larvae, in seven to ten third-instar larvae per designated genotype (UAS lines were driven by CG-GAL4). One-way ANOVA showed significant differences between means (P<0.05). Tukey's multiple comparison test showed significant differences between the means in the genotypes, when is depicted by different letters on the right-hand side of the bars (P<0.05); the genotypes with common letters showed no significant difference between the means. vesicles near the plasma membrane of fat body cells and haemocytes. In Drosophila 14-3-3 mutants, this reduction in AMP secretion would have an impact upon the capacity to kill bacteria and might explain the susceptibility to death following bacterial challenge. However, we cannot exclude the possibility that the defective accumulation of the Rab11-GFP-positive vesicles in 14-3-3 mutants impairs secretion of either other immune mediators or soluble proteins that impact upon larval viability.
A current model for cargo delivery to the plasma membrane implicates Rab4 and Rab11 in coordinated protein trafficking to the plasma membrane (Li et al., 2008; Ward et al., 2005) . According to this model, proteins are sorted into Rab4-and Rab11-positive compartments for additional sorting, and then are delivered to the plasma membrane in Rab11-positive vesicles. This function of Rab4 and Rab11 appears to be conserved in Drosophila as there were two vesicular populations in fat body cells, large Rab4-and Rab11-positve intracellular vesicles and smaller Rab11-positive vesicles. Drs resided in both of these types of vesicles, but it is probable that it is the smaller Rab11-only positive vesicles that are involved in the delivery of cargo to the plasma membrane. A role for Drosophila Rab4 and Rab11 in cargo delivery towards the plasma membrane is supported by the finding that RNAi silencing of these GTPases led to Drs accumulation, mainly in the perinuclear region. By contrast, the loss of the 14-3-3 protein resulted in Drs and small Rab11-positive vesicle accumulating near the plasma membrane of fat body cells.
In wild-type controls, 14-3-3 was found directly adjacent to Rab11-positive vesicles. Given the established function of 14-3-3 as a mediator of protein-protein interactions (Mackintosh, 2004 ), 14-3-3 might function in the assembly of the protein complex essential for the final delivery of Rab11 vesicles to and/or fusion with the plasma membrane. The capture and docking of exocytic vesicles at target membranes involves tethering factors and members of the SNARE family of proteins. In cells of the immune system, SNARE-mediated vesicle-to-plasma-membrane fusion is crucial for the release of stored inflammatory mediators and immune effectors from secretory granules (Lieu et al., 2008; Manderson et al., 2007; Murray et al., 2005; Pagan et al., 2003) . The specificity of membrane fusion events is regulated by the composition of protein complexes containing different SNAREs (Syntaxins, SNAPs, etc.), including, for instance, Syx1a (Gladycheva et al., 2007) . There was a marked similarity in the accumulation of Drs-and Rab11-positive vesicles observed in the Drosophila 14-3-3 mutants and upon Syx1a RNAi silencing. Notably, this effect closely resembles the effect of the null mutants for the vertebrate syntaxin-binding protein 1 (STXBP1; also known as UNC18-1), the crucial effector of exocytosis of cytotoxic granules in T lymphocytes (Ménasché et al., 2008; Tomas et al., 2008; Verhage and Sorensen, 2008) . A genome-wide yeast twohybrid screen has demonstrated interaction of Drosophila 14-3-3 and Syx1a (Giot et al., 2003) . In our study, there was some colocalisation between Syntaxin and 14-3-3 in fat body cells. These findings suggest a potential regulatory role for 14-3-3 in Rab11-positive vesicle delivery and/or release, which might involve Syx1a.
There is a possibility that the role of 14-3-3 in exocytosis is mediated by modulation of the cytoskeleton because 14-3-3 proteins have been previously implicated in the regulation of microtubule and actin polymerisation (Birkenfeld et al., 2003; Sadik et al., 2009; Timm et al., 2006) . In 14-3-3 mutant fat body cells, both Drs-and Rab11-positive vesicles are delivered into close proximity to the plasma membrane, indicating that the microtubule-dependent long-range trafficking is not affected (Dollar et al., 2002; RodriguezBoulan et al., 2005; Sadik et al., 2009; Sonnichsen et al., 2000; Vega and Hsu, 2001 ). The final delivery of exocytic vesicles and fusion to the plasma membrane depends on the polymerisation state of actin filaments and the integrity of actin-associated protein complexes (Jacobs et al., 2009; Yu and Bement, 2007) . In yeast, the overexpression of the dominant-negative allele of one of the 14-3-3 orthologues, Bmh2p, has been shown to cause some defects in actin organisation and vesicle targeting (Roth et al., 1999) . Despite the fact that there was no obvious disruption to F-actin organisation in our Drosophila 14-3-3 mutants, 14-3-3-mediated regulation of actin (e.g. through the actin-depolimerising factor cofilin) (Birkenfeld et al., 2003) might contribute to some actin cytoskeleton modifications at or near the plasma membrane. Thus, we cannot exclude the possibility that undetectable rearrangements have prevented the final docking of the Rab11 vesicles. Alternatively, a defect in actin dynamics at the plasma membrane could have interfered with the retrieval of these vesicles by compensatory endocytosis (Schafer, 2003) . Further investigation will be required to discern the precise molecular basis of the defect in 14-3-3 mutants.
In vertebrates, 14-3-3 proteins have been implicated in the targeting of specific cargo proteins to the plasma membrane, including delivery of the K + channel proteins KCNK3 and KNCK9, the ATP-sensitive K + channel Kir2.1 and the major histocompatibility complex (MHC) class II invariant chain (Michelsen et al., 2006; Mrowiec and Schwappach, 2006; Shikano et al., 2005) . The present study suggests that Drosophila 14-3-3 2171 14-3-3 is a regulator of innate immunity acts as a general regulator of exocytic machinery. The previously described memory dysfunction in Drosophila 14-3-3 mutants (Philip et al., 2001; Skoulakis and Davis, 1998) would support this conclusion, particularly as neurotransmitter release at neurological synapses is highly dependent on exocytosis (Menager et al., 2007) .
In summary, our results show that 14-3-3 has a crucial role in innate immunity and is essential for Drosophila viability under bacterial challenge. This crucial function in innate immunity is probably linked to the role of 14-3-3 as a regulator of AMP secretion. However, by regulating Rab11-dependent exocytosis, 14-3-3 might be implicated in other secretion processes. The discovery that 14-3-3 regulates immune secretion in Drosophila raises the question of which other proteins interact with 14-3-3 during this process. Recent proteome analysis identified some potential 14-3-3-binding partners as components of the vesicle trafficking machinery in human cells [LYST (also known as Chediak-Higashi), SEC23, VPS33B, clathrin heavy chain, Rab GTPases, and their GTPase-activating protein and guanineexchange-factor (i.e. GAP and GEF) regulators] (Jin et al., 2004; Pozuelo Rubio et al., 2004; Tchernev et al., 2002) and in Drosophila phagosomes (Stuart et al., 2007) . The scene is now set to define the molecular partners of 14-3-3 and the precise function of this protein complex in the human immune response. The specific involvement of 14-3-3 proteins in human immune-related diseases is still to be fully explored, but the in vitro interaction of mammalian 14-3-3 proteins with LYST and Sec1/Vps33B, the proteins respectively linked to Chédiak-Higashi and Hermansky-Pudlak syndromes, suggests the need for a genetic screening for 14-3-3 mutations.
Materials and Methods
Fly stocks
Unless specified, fly stocks were obtained from the Bloomington Drosophila Stock Center (Indiana University, IN). For targeted expression of genes of interest, the yeast GAL4-UAS system was used (Brand and Perrimon, 1993) . Fat-body-and haemocyte-specific expression of transgenes from the UAS was driven by CG-GAL4 (Asha et al., 2003) . RNAi and UAS-Syx1a RNAi transgenes were obtained from the Vienna Drosophila RNAi Centre (Dietzl et al., 2007) . Transgenic stocks UAS-Rab4-mRFP, UAS-Rab4 S22N and UAS-Rab11-GFP were obtained from Markos González-Gaitán (University of Geneva, Geneva, Switzerland) (Entchev et al., 2000; Wucherpfennig et al., 2003) and Donald F. Ready (Purdue University, West Lafayette, IN) (Satoh et al., 2005) . Drs-GFP was a kind gift from Dominique Ferrandon (Equipe Fondation Recherche Médicale, Strasbourg, France) (Ferrandon, 2007) . The leo1188 and the two 14-3-3 alleles used in this study, the protein-null allele 14-3-3 j2B10 (a P/SUPor-P/ insertion at position +2 of the 5Ј-UTR) and the point mutant 14-3-3 E183K , were as previously described (Acevedo et al., 2007) .
Natural bacterial infection
The early third-instar larvae were placed in petri dishes with a grape juice agar layer, covered with 100 ml of a bacterial suspension (OD 600~2 00) in 5% sucrose (E. coli DH5a for 11 hours at 25°C; M. luteus for 7 hours at 29°C). The control larvae were reared on 5% sucrose for an equal length of time. The experiments were repeated seven to ten times to achieve a sufficient sample size. To assess the survival rates following infection, larvae and pupae were scored as dead and alive at 6-hour intervals. For each group, n500-700 individual larvae were scored. Comparisons between individual data points were performed using Student's t-test. Results were considered significant if P<0.05. For gene expression qRT-PCR and Drs-GFP expression analysis, bacterial infection assays were performed at 25°C (to avoid temperature stress) for 4 hours to collect the fat body samples prior to larval death.
Gene expression analyses
For RT and qRT-PCR analysis, RNA from fat bodies from ten third-instar larvae were prepared using TRIzol reagent (Invitrogen) according to the manufacturer's protocol. cDNA was generated using the OmniScript kit protocol (Qiagen). Go Taq Green Master Mix (Promega) was used for RT-PCR, and SYBR Green qPCR kit (Qiagen) for qRT-PCR. The following primers were used for RT-PCR and qRT-PCR: Toll (CG5490) forward, 5Ј-ACATCTGCCTTTCTCCAACC-3Ј, and reverse, 5Ј-TGTTGTCCAAATGGGTTCAT-3Ј; 14-3-3 (CG31196) forward, 5Ј-AAGTCCGT-CATTAGGCCATC-3Ј, and reverse, 5Ј-TGTTCGATCGAGGTGATGAT-3Ј; PGRP-SA (CG11709) forward, 5Ј-CCTTCGTTGGGACTCCACTA-3Ј, and reverse 5Ј-CGT-GTGATGGATGACCACAT-3Ј; PGRP-LC (CG4432) forward, 5Ј-GGCAGTTC-CAATCGAAATCG-3Ј, and reverse, 5Ј-CGCTGATACGCTTGGATTCC-3Ј; rp49 (CG7939) forward, 5Ј-CAGGCCCAAGATCGTGAA-3Ј, and reverse, 5Ј-CAAATGT-GTATTCCGACC-3Ј; Drosomycin (CG10810) forward, 5Ј-GTACTTGTTCGCC-CTCTTCG-3Ј, and reverse, 5Ј-ATTTAGCATCCTTCGCACCA-3Ј; Diptericin (CG12763) forward, 5Ј-GAGATGCAGTTCACCATTG-3Ј, and reverse, 5Ј-TTTCCAGCTCGGTTCTGAGT-3Ј; Croquemort (CG4280), forward 5Ј-CCTACG-TATCCACCATGTGCT-3Ј, and reverse 5Ј-GGGTAAGGCCATCCTCTACA-3Ј. The in vivo efficiency of UAS-RNAi transgenes was assessed by qRT-PCR using the following primers: Syntaxin1a (CG31136) forward, 5Ј-TAAAGCCCGACGAAA-GAAGA-3Ј, and reverse, 5Ј-GTGGAGAGGTGTGTGTGTGG-3Ј; 14-3-3 (CG17870) forward, 5Ј-GTCACAGAGACTGGCGTTGA-3Ј, and reverse, 5Ј-GGAG-GAGATGACACGCCACGA-3Ј. For western blotting analysis, protein extracts were pulled from ten third-instar larvae of wild-type, 14-3-3 j2B10/j2B10 and 14-3-3 j2B10/E183K mutants and from 100 homozygous 14-3-3 leo1188/1188 embryos and were analysed according to the protocol described previously (Gronke et al., 2003) .
Histology and immunofluorescence analysis
Fillipin and Nile Red (both Invitrogen) staining was conducted as previously described (Gronke et al., 2007) . Antibodies used for immunofluorescence were: rabbit anti-14-3-3 antibody (two independent batches, A8 and A10, from two inoculated rabbits, a gift from Cheng-Ting Chien, Institute of Molecular Biology, Taipei, Taiwan) (Tien et al., 1999) , rabbit anti-14-3-3/Leo antibody (Kockel et al., 1997) , two independent rabbit anti-Rab11 antibodies [obtained from Robert S. Cohen (University of Kansas, Lawrence, KS) (Dollar et al., 2002) and from Akira Nakamura (Tanaka and Nakamura, 2008) ], mouse monoclonal anti-Syntaxin antibody 8C3 (Developmental Studies Hybridoma Bank, Iowa, USA) (Fujita et al., 1982) , anti-IgG secondary antibodies conjugated with biotin, Cy3, Cy5 or SA-Cy3 (Jackson ImmunoResearch Laboratories), or Alexa-Fluor-488, and Phalloidin-Alexa-Fluor-568 (Molecular Probes). Fixed and stained tissues were viewed with a Zeiss Axiophot microscope (for transmitted light), or viewed with either an Olympus Provis AX70 epifluorescence microscope or a confocal microscope equipped with a BioRad MRC1000 scanhead and a krypton/argon laser (for fluorescence). Confocal micrographs represent 1-mm optical sections.
Tissues for transmission electron microscopy (TEM) analysis were prepared according as described previously (Kohler et al., 2009 ) and viewed with a Philips Technai 12 transmission electron microscope (The Centre for Microscopy and Microanalysis, The University of Queensland, Australia).
To test for secretion of Drs-GFP into the haemolymph, we bacterially challenged third-instar larvae of wild-type or 14-3-3 mutant genotypes carrying a Drs-GFP transgene. After 4 hours of challenge, the level of GFP fluorescence in larvae was checked under the fluorescent dissection microscope (Olympus, Japan) and if detected, haemolymph was collected from each larvae by gently puncturing with a 26-gauge needle to let the haemolymph bleed onto a coverslip. The exposure to air induces a rapid and extensive coagulation of insect haemolymph, entrapping haemocytes within the clot (Bidla et al., 2005; Karlsson et al., 2004; Scherfer et al., 2004) . The distinct composition of the insect clot (Theopold et al., 2002) makes it insensitive to detergent and vertebrate anti-coagulation reagents. To overcome this problem, the quantitative analysis of the Drs-GFP signal in haemolymph was carried out before the formation of an insoluble clot: immediately after bleeding, the drop of haemolymph was covered with mineral oil and the intensity of fluorescent signal was quantified in the haemocyte-free regions of the haemolymph in 3-mm confocal sections (BioRad MRC1000 scanhead and a krypton-argon laser). A total of 12 larvae per genotype (at least three independent regions per larvae) were analysed.
Statistical analysis
Data are presented as means±s.e.m. The difference between group means was assessed by one-way analysis of variance (ANOVA), with individual group variance assessed by a Bartlett's test. Where the level of significance was P<0.05, post-hoc tests were performed using a Tukey's multiple comparison test (GraphPad Prism software).
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